药品商业标识注册问题研究

发布时间：2019-02-10 19:29

【摘要】：药品通用名、商品名、商标及药品生产企业字号等标识之间冲突的现象比较普遍。以消费者调查报告为基础,健全药品约定俗成通用名的司法认定规则,合理划分公有领域与专有领域的界限,可以维护公平竞争的市场秩序;药品通用名不得注册为药品商标,对不当载入药典的通用名,应当允许当事人有条件申请更正。通过合理规范药品商业标识的注册,可以防止消费者混淆,保障患者用药安全。
[Abstract]:Conflicts between generic drug names, trade names, trademarks and drug manufacturing companies are common. On the basis of the consumer investigation report, we should perfect the rules of judicial recognition of the common name of drugs and reasonably divide the boundaries between the public domain and the exclusive field, which can maintain the market order of fair competition. Generic drug name may not be registered as a drug trademark, and the parties shall be allowed to apply for correction of the generic name inappropriately entered in the Pharmacopoeia. By reasonably standardizing the registration of drug commercial marks, we can prevent consumer confusion and ensure the safety of drug use by patients.
【作者单位】：常州大学知识产权研究中心;常州市知识产权维权援助中心;
【基金】：国家社科基金项目《知识产权诉讼技术事实查明机制研究》(15BFX135)的阶段性研究成果常州市科技局软课题《常州市建设知识产权强市的路径、政策和主要任务》的阶段性研究成果
【分类号】：D923.43

【参考文献】